126 related articles for article (PubMed ID: 25964558)
1. Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
Arzuman L; Beale P; Yu JQ; Huq F
Anticancer Res; 2015 May; 35(5):2783-94. PubMed ID: 25964558
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
[TBL] [Abstract][Full Text] [Related]
3. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines.
Arzuman L; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2014 Oct; 34(10):5453-64. PubMed ID: 25275041
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
5. Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models.
Arzuman L; Beale P; Proschogo N; Yu JQ; Huq F
Anticancer Res; 2015 Nov; 35(11):6027-39. PubMed ID: 26504026
[TBL] [Abstract][Full Text] [Related]
6. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.
Nessa MU; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Nov; 32(11):4843-50. PubMed ID: 23155250
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of tris(quinoline)monochloroplatinum(II) Chloride and its Activity Alone and in Combination with Capsaicin and Curcumin in Human Ovarian Cancer Cell Lines.
Arzuman L; Beale P; Yu JQ; Huq F
Anticancer Res; 2016 Jun; 36(6):2809-18. PubMed ID: 27272792
[TBL] [Abstract][Full Text] [Related]
8. Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer.
Huq F; Yu JQ; Beale P; Chan C; Arzuman L; Nessa MU; Mazumder ME
Anticancer Res; 2014 Jan; 34(1):541-5. PubMed ID: 24403514
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
Hamad SA; Beale P; Yu JQ; Huq F
Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
[TBL] [Abstract][Full Text] [Related]
10. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells.
Yunos NM; Beale P; Yu JQ; Huq F
Anticancer Res; 2011 Apr; 31(4):1131-40. PubMed ID: 21508356
[TBL] [Abstract][Full Text] [Related]
11. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.
Yunos NM; Beale P; Yu JQ; Strain D; Huq F
Anticancer Res; 2010 Oct; 30(10):4025-37. PubMed ID: 21036717
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
Mazumder ME; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Nov; 32(11):4851-60. PubMed ID: 23155251
[TBL] [Abstract][Full Text] [Related]
13. Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.
Yunos NM; Beale P; Yu JQ; Huq F
Anticancer Res; 2011 Dec; 31(12):4283-9. PubMed ID: 22199293
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
[TBL] [Abstract][Full Text] [Related]
15. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.
Nessa MU; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2011 Nov; 31(11):3789-97. PubMed ID: 22110201
[TBL] [Abstract][Full Text] [Related]
16. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.
Nessa MU; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Jan; 32(1):53-9. PubMed ID: 22213288
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers.
Sarwar S; Alamro AA; Alghamdi AA; Naeem K; Ullah S; Arif M; Yu JQ; Huq F
Drug Des Devel Ther; 2021; 15():2211-2227. PubMed ID: 34079223
[TBL] [Abstract][Full Text] [Related]
18. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cisplatin cytotoxicity due to its combination with bortezomib and the nature of its administration.
Al-Eisawi Z; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2011 Sep; 31(9):2757-62. PubMed ID: 21868517
[TBL] [Abstract][Full Text] [Related]
20. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.
Althurwi SI; Yu JQ; Beale P; Huq F
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]